Advertisement
Advertisement
U.S. markets open in 3 hours 47 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Fate Therapeutics, Inc. (FATE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Visitors trend2W10W9M
19.14-1.26 (-6.18%)
At close: 04:00PM EST
19.15 +0.01 (+0.05%)
After hours: 06:45PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Performance Outlook
Previous Close20.40
Open20.40
Bid0.00 x 800
Ask0.00 x 800
Day's Range19.04 - 20.40
52 Week Range17.10 - 66.56
Volume1,133,796
Avg. Volume1,294,145
Market Cap1.86B
Beta (5Y Monthly)1.56
PE Ratio (TTM)N/A
EPS (TTM)-2.44
Earnings DateFeb 27, 2023 - Mar 03, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est65.43
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for FATE

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Fate Therapeutics, Inc.
    Daily – Vickers Top Buyers & Sellers for 01/14/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    11 months agoArgus Research
View more
  • Insider Monkey

    9 Cheap Stocks to Buy According to Cathie Wood

    In this article, we discuss the 9 cheap stocks to buy according to Cathie Wood. If you want to skip our detailed analysis of these stocks, go directly to 4 Cheap Stocks to Buy According to Cathie Wood. Cathie Wood’s hedge fund ARK Investment Management has been battered this year as investors exit growth stocks […]

  • GlobeNewswire

    Fate Therapeutics Announces Exercise by ONO Pharmaceutical of Option to HER2-targeted CAR T-Cell Product Candidate for Solid Tumors

    Multiplexed-engineered, iPSC-derived CAR T-cell Product Candidate Demonstrated Broad, Potent and Specific CAR Activity Across Multiple Preclinical Solid Tumor Models Fate and ONO to Jointly Develop and Commercialize FT825/ONO-8250 in U.S. and Europe with ONO having Exclusive Rights in Rest of World SAN DIEGO, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for

  • GlobeNewswire

    Fate Therapeutics to Present at Upcoming Investor Conferences

    SAN DIEGO, Nov. 04, 2022 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for patients with cancer, today announced that the Company will present at the following upcoming investor conferences: Cowen’s 6th Annual IO Next Summit available on demand on Friday, November 11, 2022 at 2:10 PM ETJefferies London Healthcare Conference on Wednesd

Advertisement
Advertisement